| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Implications of the fragility of opioid agonist treatment continuity on hepatitis C re-exposure concerns among people in prison: a qualitative study.
Implications of the fragility of opioid agonist treatment continuity on hepatitis C re-exposure concerns among people in prison: a qualitative study.
Lafferty L, Brown T, McGrath C, Wright T, Henderson C, Lloyd AR, Grebely J, Treloar C.
Int J Drug Policy. 2025 May 19;142:104831. doi: 10.1016/j.drugpo.2025.104831. Epub ahead of print. PMID: 40393090.
https://www.sciencedirect.com/science/article/pii/S0955395925001318